Cancer Biopsy Market Size, Share Report, Analysis, Trends, Growth, Forecast, 2024 - 2032
Cancer Biopsy Market - By Product (Kits & Consumables and Instruments), By Type (Tissue Biopsies and Liquid Biopsies), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 5.22 Billion | USD 79.78 Billion | 35.4% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Type
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Cancer Biopsy Market, 2018–2028(USD Billion)
- 2.2. Cancer Biopsy Market: Snapshot
- Chapter 3. Global Cancer Biopsy Market– Type Analysis
- 3.1. Cancer Biopsy Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Massive application of liquid biopsy and breakthroughs in biopsy methods are set to spur growth of cancer biopsy market in upcoming years.
- 3.2.2. Launching of new methods like next-generation sequencing will embellish industry size within next few years.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Product
- 3.4.2. Market attractiveness analysis By Type
- Chapter 4. Global Cancer Biopsy Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Cancer Biopsy Market: company market share, 2019
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Cancer Biopsy Market– Product Analysis
- 5.1. Global Cancer Biopsy Market overview: By Product
- 5.1.1. Global Cancer Biopsy Market share, By Product, 2020 and 2028
- 5.2. Kits & Consumables
- 5.2.1. Global Cancer Biopsy Market by Kits & Consumables, 2018–2028(USD Billion)
- 5.3. Instruments
- 5.3.1. Global Cancer Biopsy Market by Instruments, 2018–2028(USD Billion)
- 5.1. Global Cancer Biopsy Market overview: By Product
- Chapter 6. Global Cancer Biopsy Market– Type Analysis
- 6.1. Global Cancer Biopsy Market overview: By Type
- 6.1.1. Global Cancer Biopsy Market share, By Type, 2020 and 2028
- 6.2. Tissue Biopsies
- 6.2.1. Global Cancer Biopsy Market by Tissue Biopsies , 2018–2028(USD Billion)
- 6.3. Liquid Biopsies
- 6.3.1. Global Cancer Biopsy Market by Liquid Biopsies, 2018–2028(USD Billion)
- 6.1. Global Cancer Biopsy Market overview: By Type
- Chapter 7. Company Profiles
- 7.1. Qiagen N.V.
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Product Portfolio
- 7.1.4. Business Strategy
- 7.1.5. Recent Developments
- 7.2. Hulogic, Inc.
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Product Portfolio
- 7.2.4. Business Strategy
- 7.2.5. Recent Developments
- 7.3. Illumina, Inc.
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Product Portfolio
- 7.3.4. Business Strategy
- 7.3.5. Recent Development
- 7.4. Biocept, Inc.
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Product Portfolio
- 7.4.4. Business Strategy
- 7.4.5. Recent Development
- 7.5. ANGLE Plc
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Product Portfolio
- 7.5.4. Business Strategy
- 7.5.5. Recent Development
- 7.6. Danaher Corporation
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Product Portfolio
- 7.6.4. Business Strategy
- 7.6.5. Recent Development
- 7.7. Roche Hulding AG
- 7.7.1. Overview
- 7.7.2. Financials
- 7.7.3. Product Portfolio
- 7.7.4. Business Strategy
- 7.7.5. Recent Development
- 7.8. GRAIL, Inc.
- 7.8.1. Overview
- 7.8.2. Financials
- 7.8.3. Product Portfolio
- 7.8.4. Business Strategy
- 7.8.5. Recent Development
- 7.9. Freenome Huldings, Inc.
- 7.9.1. Overview
- 7.9.2. Financials
- 7.9.3. Product Portfolio
- 7.9.4. Business Strategy
- 7.9.5. Recent Development
- 7.10. Lucence Diagnostics Private Limited
- 7.10.1. Overview
- 7.10.2. Financials
- 7.10.3. Product Portfolio
- 7.10.4. Business Strategy
- 7.10.5. Recent Development
- 7.11. Epigenomics AG
- 7.11.1. Overview
- 7.11.2. Financials
- 7.11.3. Product Portfolio
- 7.11.4. Business Strategy
- 7.11.5. Recent Development
- 7.12. HelioHealth
- 7.12.1. Overview
- 7.12.2. Financials
- 7.12.3. Product Portfolio
- 7.12.4. Business Strategy
- 7.12.5. Recent Development
- 7.13. Genesystems, Inc.
- 7.13.1. Overview
- 7.13.2. Financials
- 7.13.3. Product Portfolio
- 7.13.4. Business Strategy
- 7.13.5. Recent Development
- 7.14. Natera, Inc.
- 7.14.1. Overview
- 7.14.2. Financials
- 7.14.3. Product Portfolio
- 7.14.4. Business Strategy
- 7.14.5. Recent Development
- 7.15. Chronix Biomedical, Inc.
- 7.15.1. Overview
- 7.15.2. Financials
- 7.15.3. Product Portfolio
- 7.15.4. Business Strategy
- 7.15.5. Recent Development
- 7.16. Personal Genome Diagnostics Inc.
- 7.16.1. Overview
- 7.16.2. Financials
- 7.16.3. Product Portfolio
- 7.16.4. Business Strategy
- 7.16.5. Recent Development
- 7.17. Personalis, Inc.
- 7.17.1. Overview
- 7.17.2. Financials
- 7.17.3. Product Portfolio
- 7.17.4. Business Strategy
- 7.17.5. Recent Development
- 7.18. Biodesix
- 7.18.1. Overview
- 7.18.2. Financials
- 7.18.3. Product Portfolio
- 7.18.4. Business Strategy
- 7.18.5. Recent Development
- 7.1. Qiagen N.V.
Table Of Figures
List of Figures
1. Market research Type
2. Market research methodology
3. Global Cancer Biopsy Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Cancer Biopsy Marketattractiveness, By Product
6. Global Cancer Biopsy Marketattractiveness, By Type
7. Global Cancer Biopsy Marketshare by Product ,2020 and 2028 (USD Billion)
8. Global Cancer Biopsy Marketby Kits & Consumables, 2018–2028(USD Billion)
9. Global Cancer Biopsy Marketby Instruments, 2018–2028(USD Billion)
10. Global Cancer Biopsy Marketshare by Type ,2020 and 2028 (USD Billion)
11. Global Cancer Biopsy Marketby Tissue Biopsies , 2018–2028(USD Billion)
12. Global Cancer Biopsy Marketby Liquid Biopsies, 2018–2028(USD Billion)
13. Global Cancer Biopsy Marketshare, by Region, 2020 and 2028
14. North America Cancer Biopsy Market, 2018–2028(USD Billion)
15. Europe Cancer Biopsy Market, 2018–2028(USD Billion)
16. Asia Pacific Cancer Biopsy Market, 2018–2028(USD Billion)
17. Latin America Cancer Biopsy Market, 2018–2028(USD Billion)
18. The Middle East and Africa Cancer Biopsy Market, 2018–2028(USD Billion)
Table Of Tables
List of Tables
1. Global Cancer Biopsy Market: snapshot
2. Drivers of the Cancer Biopsy Market: impact analysis
3. North America Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
4. North America Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
5. The U.S. Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
6. The U.S. Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
7. Rest of North America Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
8. Rest of North America Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
9. Europe Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
10. Europe Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
11. UK Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
12. UK Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
13. France Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
14. France Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
15. Germany Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
16. Germany Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
17. Rest of Europe Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
18. Rest of Europe Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
19. Asia Pacific Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
20. Asia Pacific Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
21. China Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
22. China Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
23. Japan Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
24. Japan Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
25. India Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
26. India Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
27. Rest of Asia Pacific Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
28. Rest of Asia Pacific Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
29. Latin America Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
30. Latin America Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
31. Brazil Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
32. Brazil Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
33. Rest of Latin America Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
34. Rest of Latin America Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
35. The Middle East and Africa Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
36. The Middle East and Africa Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
37. Saudi Arabia Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
38. Saudi Arabia Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
39. South Africa Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
40. South Africa Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
41. Rest of the Middle East & Africa Cancer Biopsy Market revenue, By Product ,2018–2028(USD Billion)
42. Rest of the Middle East & Africa Cancer Biopsy Market revenue, By Type ,2018–2028(USD Billion)
Methodology
FrequentlyAsked Questions
Massive application of liquid biopsy and breakthroughs in biopsy methods are slated to steer expansion of cancer biopsy market over forthcoming years. In addition to this, minimal invasive nature of deriving circulating tumor cells has made biopsy as most popular tool in detecting various kinds of cancer in patients. Apparently, introduction of new techniques such as next-generation sequencing will embellish industry space in upcoming years. Furthermore, a prominent role played by image-driven needle biopsies in domain of precision medicine will proliferate size of cancer biopsy market over ensuing years.
Moreover, surging molecular assays is key to expansion of cancer biopsy industry. Additionally, in clinical studies, biopsies are also utilized for identifying drug response rate for patients receiving epidermal growth factor receptor treatments. This will further drive market trends. Apart from this, increase in number of medical trials in biomarker research activities will expand cancer biopsy market size.
According to Zion market research report, the global cancer biopsy market accrued earnings worth approximately USD 5.22 Billion in 2023 and projected to USD 79.78 Billion by 2032, with a CAGR of around 35.4% between 2024-2032.
North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to prominent surge in number of diagnostic kit manufacturers & distributors in the sub-continent. Rise in acceptance of liquid biopsies in the U.S. will create lucrative growth avenues for cancer biopsy industry in North America during assessment period.
The key market participants include Qiagen N.V., Hologic, Inc., Illumina, Inc., Biocept, Inc., ANGLE Plc, Danaher Corporation, Roche Holding AG, GRAIL, Inc., Freenome Holdings, Inc., Lucence Diagnostics Private Limited, Epigenomics AG, HelioHealth, Genesystems, Inc., Natera, Inc., Chronix Biomedical , Inc., Personal Genome Diagnostics Inc., Personalis Inc., and Biodesix.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed